Catalog of 5’ Fusion Partners in ALK-positive NSCLC Circa 2020

Since the discovery of anaplastic lymphoma kinase fusion-positive (ALK+) NSCLC in 2007, the methods to detect ALK+ NSCLC have evolved and expanded from fluorescence in situ hybridization and immunohistochemistry to next-generation DNA sequencing, targeted RNA sequencing, and whole transcriptome sequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Sai-Hong Ignatius, Zhu, Viola W., Nagasaka, Misako
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474466/
https://www.ncbi.nlm.nih.gov/pubmed/34589917
http://dx.doi.org/10.1016/j.jtocrr.2020.100015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474466/
https://www.ncbi.nlm.nih.gov/pubmed/34589917
http://dx.doi.org/10.1016/j.jtocrr.2020.100015

Ejemplares similares